Are smoking and alcohol relevant to lichen sclerosus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Smoking and Alcohol Are Not Established Risk Factors for Lichen Sclerosus

Based on the available evidence, neither smoking nor alcohol consumption appear to be relevant risk factors for lichen sclerosus, and there is even emerging evidence suggesting alcohol may have a protective effect in males.

Evidence Summary

Smoking

The relationship between smoking and lichen sclerosus is inconsistent and likely not clinically significant:

  • A 2024 study of 487 adult male patients with genital lichen sclerosus found that 36% had been smokers at some point—a rate the authors considered "probably unremarkable compared with available data for smoking habits from the United Kingdom" 1
  • The 2018 British Association of Dermatologists guideline notes that male lichen sclerosus has been "associated with tobacco use" 2, but this appears to be a weak association without clear causality
  • A 1989 case-control study of 75 women with vulvar lichen sclerosus found "no difference" in smoking habits between cases and controls 3

Clinical implication: While general health counseling about smoking cessation remains appropriate, smoking does not appear to be a modifiable risk factor specifically for lichen sclerosus development or progression.

Alcohol

The evidence regarding alcohol is even more limited and suggests no harmful association:

  • A 2023 case-control study of 94 male patients found that alcohol consumption was actually a protective factor against lichen sclerosus (p=0.027) 4
  • The same 1989 study that examined smoking found no association between alcohol and vulvar lichen sclerosus 3
  • No major guidelines on lichen sclerosus management 5, 2 mention alcohol as a risk factor or disease modifier

Clinical implication: There is no evidence-based reason to counsel lichen sclerosus patients about alcohol consumption as it relates to their skin condition.

Important Caveat

The evidence cited from psoriasis guidelines 6 regarding smoking and alcohol is not applicable to lichen sclerosus—these are entirely different disease processes with different pathophysiology. Lichen sclerosus is a chronic lymphocyte-mediated inflammatory dermatosis, not an immune-mediated systemic disease like psoriasis.

What Actually Matters for Lichen Sclerosus

Instead of focusing on smoking or alcohol, clinicians should address the actual established risk factors and associations 2, 4:

  • Diabetes mellitus (significantly higher rates in lichen sclerosus patients, p=0.021)
  • Hypertension (significantly higher rates, p=0.004)
  • Obesity/elevated BMI (associated with male genital lichen sclerosus)
  • Moisture and occlusion (urinary microincontinence, uncircumcised status in males)
  • Trauma (can trigger disease through Koebnerization)
  • Autoimmune conditions (thyroid disease, vitiligo, alopecia areata in females)

References

3
Research

Risk factors for vulvar lichen sclerosus.

American journal of obstetrics and gynecology, 1989

Related Questions

What is the recommended treatment for a lichen sclerosus flare?
What is the recommended workup for suspected lichen sclerosus of the scrotum (testicular involvement)?
What is the appropriate treatment for lichen sclerosus involving the axilla and vulva, and should the patient be referred to both a dermatologist and a gynecologist for management?
What is the recommended first-line treatment for lichen sclerosus?
What is the treatment for lichen sclerosus and which medical specialty manages it?
If my patient is having hemoptysis, should I obtain a chest computed tomography (CT) scan?
What is the appropriate management for an infusion reaction to amivantamab?
What is the appropriate assessment and plan for a 79‑year‑old woman with a history of coronary artery disease status post triple coronary artery bypass graft (left internal mammary artery to left anterior descending artery and saphenous vein grafts to obtuse marginal branches), hypertension, hyperlipidemia, chronic obstructive pulmonary disease, obstructive sleep apnea, and heart failure with reduced ejection fraction (35‑40 %), who presented with severe hypertension and chest pain, was diagnosed with a non‑ST‑elevation myocardial infarction, underwent percutaneous coronary intervention with a drug‑eluting stent to the obtuse marginal branch, and now has bradycardia, hypotension, mildly elevated creatinine, and is taking aspirin, ticagrelor, bempedoic‑acid/ezetimibe, losartan/hydrochlorothiazide, isosorbide mononitrate, and sertraline?
What is the most common cause of mortality in patients with familial Mediterranean fever?
Given a mean corpuscular volume of 78.4 fL, total iron‑binding capacity of 33 µg/dL, and ferritin of 196 ng/mL, does this indicate iron‑deficiency anemia?
What is the prognosis for bilateral cerebellar hemisphere lesions and a right posterior parietal lobe lesion?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.